The association between alcohol consumption and decreased risk of coronary heart disease is well established, but possible age differences are plausible because of potential pathogenic differences in coronary heart disease events occurring in younger compared with middle-aged or older individuals. We studied these relations in a large population of men and women 35 to 89 years of age at baseline. We observed a lower risk of coronary heart disease among men and women with a light to moderate alcohol intake compared with nondrinkers, and this finding was consistent and of similar size in all age groups. However, the absolute risk of CHD was small in the youngest age group, and risk differences between abstainers and light to moderate alcohol consumers were of negligible size. Therefore, our results provide strong evidence for a lower risk of coronary heart disease among moderate consumers relative to nondrinkers in younger, middleaged, and older adults; however, considering absolute risks across age groups, younger adults are not likely to benefit from an overall recommendation of moderate alcohol intake. See p 1589.
Nocturnal Rostral Fluid Shift: A Unifying Concept for the Pathogenesis of Obstructive and Central Sleep Apnea in Men With Heart Failure
Obstructive and central sleep apnea (OSA and CSA, respectively) occur commonly in patients with heart failure (HF) and are associated with increased mortality. However, causes of these breathing disorders are not well established in the setting of HF but are thought to arise through different mechanisms: OSA through obesity and anatomic narrowing of the pharynx, and CSA through hypocapnia and increased chemoreceptor sensitivity. However, the observation that OSA and CSA can occur simultaneously in HF patients suggested a common pathophysiological mechanism linking these 2 disorders. Because HF is a fluid-retaining state, we hypothesized that overnight displacement of fluid from the legs into the neck might lead to OSA by narrowing the pharynx and to CSA if fluid shifted into the lungs and caused stimulation of vagal receptors that stimulate hyperventilation and lower PCO 2 . We confirmed these hypotheses in HF patients by demonstrating that the degree of overnight shift of fluid from the legs was related to the severity of sleep apnea as determined by the apnea-hypopnea index. In the case of OSA, this was through a concomitant increase in neck circumference. In the case of CSA, this was through an inverse relationship with PCO 2 , presumably because of fluid movement into the lungs. Thus, a common mechanism linking OSA and CSA in HF patients is fluid retention and overnight rostral fluid displacement. These novel findings suggest that manipulation of fluid status may be a novel means by which to treat OSA and CSA in HF patients. See p 1598.
Elevated Cytosolic Na ؉ Increases Mitochondrial Formation of Reactive Oxygen Species in Failing Cardiac Myocytes
Oxidative stress plays a fundamental role in cardiovascular diseases and aging. In patients with heart failure, oxidative stress is causally linked to the progression of the disease, and mitochondria were identified as critical sources of reactive oxygen species (ROS) in the heart. ROS impair cardiac contractility, cause arrhythmias, and contribute to cardiac remodeling by inducing hypertrophy, apoptosis, and necrosis. The precise mechanisms that regulate mitochondrial ROS formation, however, are incompletely understood. Here, we identified a mechanism by which an elevation of cytosolic sodium ([Na ϩ ] i ), as occurs in failing cardiac myocytes, increases mitochondrial ROS formation. A key role is played by the Krebs cycle, which produces NADH, the main electron donor for ATP production at the respiratory chain. A less appreciated role of the Krebs cycle, however, is to indirectly support the regeneration of NADPH, which serves to maintain the antioxidative capacity of the mitochondrial matrix. During transitions of workload (eg, during ␤-adrenergic stimulation), mitochondrial Ca 2ϩ uptake activates rate-controlling enzymes of the Krebs cycle to adapt NADH production to an increased energetic demand. The elevated [Na ϩ ] i in failing myocytes induces Ca 2ϩ exportation from mitochondria via an Na ϩ /Ca 2ϩ exchanger, which hampers regeneration of NADH and NADPH, resulting in energetic mismatch and oxidative stress. The effects of cytosolic Na ϩ on mitochondrial function described in the present study indicate that this mechanism could play a role in the toxicity of cardiac glycosides (which further increase [Na ϩ ] i ) and suggest a potential therapeutic application for drugs that lower [Na ϩ ] i during the progression of heart failure. See p 1606.
DEFI 2005: A Randomized Controlled Trial of the Effect of Automated External Defibrillator Cardiopulmonary Resuscitation Protocol on Outcome From Out-of-Hospital Cardiac Arrest
The American Heart Association Guidelines 2005 for Emergency Cardiac Care made changes to the way that chest compressions, ventilations, and defibrillation countershocks are sequenced in an effort to resuscitate more patients in cardiac arrest. These changes, which were based on theoretical considerations, experimental studies, and few clinical studies, aimed to increase cardiopulmonary resuscitation (CPR) in hopes of improving patient outcomes. Although several published articles have reported on the effect of increasing CPR in cohort studies, none has the evidence level of a randomized controlled trial. The results of this 18-month, 845patient, randomized controlled trial on out-of-hospital ventricular fibrillation cardiac arrest are of particular interest and potential impact on the next cycle of the evidence review process of the International Liaison Committee on Resuscitation, leading to the American Heart Association 2010 Guidelines. This randomized controlled trial demonstrated that, by following new automated external defibrillator prompts, basic life support-trained firefighters could shorten pauses in chest compressions and improve their overall CPR hands-on ratio from 48% to 61% during resuscitation of patients with ventricular fibrillation out-of-hospital cardiac arrest. However, this improvement in CPR metrics did not translate into measurable differences in rates of return of spontaneous circulation before advanced cardiac life support arrival, survival to hospital admission or discharge, or 1-year survival. The lack of benefit from increased CPR in this trial, combined with experience from this and other emergency medical systems, suggests that the survival rate may be further improved by efforts focused on other changes to community resuscitation such as increasing bystander CPR, shortening response times, or even providing more extensive and regular CPR training to rescuers. See p 1614.
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Prevalence of Asymptomatic Coronary Artery Disease in Ischemic Stroke Patients: The PRECORIS Study
Coronary artery disease (CAD) is a significant cause of morbidity and mortality in stroke patients. Using 64-section CT coronary angiography, we assessed the prevalence of Ն50% asymptomatic CAD in 274 consecutive patients with ischemic stroke or transient ischemic attack and whether asymptomatic CAD is related to traditional risk factors and cervicocephalic atherosclerosis. The prevalence of Ն50% asymptomatic CAD was 18% (95% confidence interval, 14 to 23). Asymptomatic CAD was independently associated with traditional risk factors assessed individually and through the Framingham Risk Score, the presence of at least 1 Ն50% cervicocephalic artery stenosis, excessive alcohol consumption, and ankle brachial index Ͻ0.9. The prevalence of Ն50% asymptomatic CAD was also related to the extent of cervicocephalic atherosclerosis. The majority of patients (75%) with Ն50% asymptomatic CAD and 90% of those with 3-vessel disease or left main trunk disease had either a 10-year-risk of coronary heart disease Ն20% according to the Framingham Risk Score or at least 1 Ն50% cervicocephalic artery stenosis. This subset of stroke patients accounted for 40% of the study population. This study cannot address the value of screening for asymptomatic CAD. The decision to screen for asymptomatic CAD stroke patients and the need for coronary revascularization should be addressed by standard algorithms as suggested by national guidelines. See p 1623.
Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism: The Vienna Prediction Model
Venous thromboembolism (VTE) is a common disease with a high recurrence risk that is particularly high among patients in whom VTE occurred in the absence of a triggering factor. These patients are candidates for indefinite anticoagulation. Despite the high recurrence risk, the majority of patients will remain recurrence free for many years and will unnecessarily be exposed to a bleeding risk with treatment. Therefore, identification of patients in whom the risk of recurrence is low enough to consider short-term anticoagulation is a major goal in patient management. It was our aim to develop a simple risk assessment model in patients with unprovoked VTE. In a prospective cohort study, 929 patients were followed up for a median of 43.3 months after discontinuation of anticoagulation. A total of 176 patients (18.9%) had recurrent VTE. Preselected clinical and laboratory variables (age, sex, location of VTE, body mass index, factor V Leiden, prothrombin G20210A mutation, D-dimer, and in vitro thrombin generation) were analyzed, and those that were significantly associated with recurrence were used to compute risk scores. The combination of location of the initial VTE event and the patient's sex together with D-dimer levels was well suited to discriminate between low-and high-risk patients. With these variables, we developed a nomogram that can be used to calculate risk scores and to estimate the cumulative probability of recurrence in an individual patient. In conclusion, by use of a simple scoring system, the assessment of the recurrence risk in patients with a first unprovoked VTE can be improved. See p 1630.
Overexpression of Urokinase by Plaque Macrophages Causes Histological Features of Plaque Rupture and Increases Vascular Matrix Metalloproteinase Activity in Aged Apolipoprotein E-Null Mice
Rupture of previously stable atherosclerotic plaques causes unstable angina, myocardial infarctions, and strokes. However, the mechanisms that cause plaque rupture are not yet understood. If these mechanisms could be identified, therapies might be developed that prevent plaque rupture. The most widely held mechanistic hypothesis relative to plaque rupture is that it is caused by increased activity of plaque proteolytic enzymes including urokinase, plasmin, and matrix metalloproteinases. This hypothesis is supported by histological analyses of human plaques that show active proteases in ruptured plaques and by clinical studies that associate higher levels of proteolytic activity (in plasma) with major cardiovascular events. However, these studies do not prove causality, and a large number of animal studies have not revealed a reliable cause-and-effect relationship between plaque proteolytic activity and histological features of plaque rupture. Here we generated a new animal model in which we introduce macrophages that express high levels of urokinase into advanced atherosclerotic plaques in mice. Arteries from these mice have elevated proteolytic activity, including high levels of both plasminogen activator and matrix metalloproteinase activity. Compared with control mice, mice with urokinase-type plasminogen activator-overexpressing macrophages have a significantly higher (61% versus 13%) prevalence of intraplaque hemorrhage as well as a higher prevalence of plaque cap disruption and fibrin(ogen) staining (features found in ruptured human plaques). These data provide experimental support for a mechanistic connection between macrophage urokinase-type plasminogen activator expression, matrix metalloproteinase activity, and plaque rupture. These data also support a causal link between elevated plaque plasminogen activator expression, plaque rupture, and cardiovascular events in humans. See p 1637.
